Ke-Qing Li
Overview
Explore the profile of Ke-Qing Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhang Y, Li K, Sun J, Li W, Tong Z, Yan B, et al.
Psychiatr Q
. 2018 Apr;
89(3):757-763.
PMID: 29637466
In 2006, the "unlocking program" was implemented in Hebei province, China to promote the human rights for people with severe mental illness who were physically restrained at home. We assessed...
12.
Aberrant intrinsic functional connectivity in thalamo-cortical networks in major depressive disorder
Kong Q, Qiao H, Liu C, Zhang P, Li K, Wang L, et al.
CNS Neurosci Ther
. 2018 Mar;
24(11):1063-1072.
PMID: 29493113
Objective: Growing evidence has implicated dysfunction of the thalamus and its projection cortical targets in depression. However, the anatomical specificity of thalamo-cortical connectivity in major depressive disorder (MDD) remains unknown...
13.
Su Y, Yan F, Li Q, Xiang Y, Shu L, Yu X, et al.
Psychiatry Res
. 2017 Jul;
257:132-136.
PMID: 28755603
Our previous study demonstrated that there have been changes in the patterns of prescription antipsychotic use in China over the period from 2002 to 2012. The aim of this study...
14.
Li Q, Su Y, Xiang Y, Shu L, Yu X, Ungvari G, et al.
Hum Psychopharmacol
. 2017 Jan;
32(1).
PMID: 28120487
Objective: This study examined the pattern of adjunctive antidepressant use in schizophrenia patients and its demographic and clinical correlates in a nationwide survey in China. Methods: Fourteen thousand and thirteen...
15.
Li Y, Zhang Y, Wang J, Li K, Wang H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
. 2017 Jan;
38(6):666-678.
PMID: 28065233
Objective To systematically evaluate the efficacy of clozapine combined with other antipsychotic drugs in the treatment of refractory schizophrenia. Methods We searched Medline, EMBASE, and China Biology Medicine databases in...
16.
Li Q, Su Y, Xiang Y, Shu L, Yu X, Ungvari G, et al.
J ECT
. 2016 Oct;
33(2):138-142.
PMID: 27753759
Objective: Little is known about electroconvulsive therapy (ECT) use in the treatment of schizophrenia in China. This study examined the frequency of ECT use, its trend between 2006 and 2012,...
17.
Li Q, Xiang Y, Su Y, Shu L, Yu X, Correll C, et al.
Schizophr Res
. 2015 Aug;
168(1-2):523-9.
PMID: 26277534
Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China. Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide...
18.
Liang Y, Su Y, Zhao Z, Gao N, Huang J, Tang M, et al.
J Clin Psychopharmacol
. 2015 Aug;
35(5):583-6.
PMID: 26270200
Objective: This prospective study sought to compare the acute effects of haloperidol, amisulpride, and quetiapine on serum markers of bone formation and resorption in relatively young patients with minimal previous...
19.
Wang Y, Xiang Y, Su Y, Li Q, Shu L, Ng C, et al.
Chin Med J (Engl)
. 2015 Jul;
128(14):1847-52.
PMID: 26168821
Background: Optimizing treatment outcomes for depression requires understanding of how evidence-based treatments are utilized in clinical practice. Antipsychotic medications concurrent with antidepressant treatment are frequently used in major depression, but...
20.
Li Q, Xiang Y, Su Y, Shu L, Yu X, Chiu H, et al.
Aust N Z J Psychiatry
. 2014 Jun;
49(2):129-36.
PMID: 24923760
Objective: This study examined the use, demographic and clinical correlates of antipsychotic polypharmacy (APP) and its associations with treatment satisfaction and quality of life (QOL) in schizophrenia patients in China....